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Recently, in vitro selection using mRNA display was used to identify a
novel peptide sequence that binds with high affinity to Gi1. The peptide
was minimized to a 9-residue sequence (R6A-1) that retains high affinity
and specificity for the GDP-bound state of Gi1 and acts as a guanine
nucleotide dissociation inhibitor (GDI). Here, we demonstrate that the
R6A-1 peptide interacts with G subunits representing all four G protein
classes, acting as a core motif for G interaction. This contrasts with the
consensus G protein regulatory (GPR) sequence, a 28-mer peptide GDI
derived from the GoLoco (Gi/o-Loco interaction)/GPRmotif that shares
no homologywith R6A-1 and binds only toGi1–3 in this assay. Binding of
R6A-1 is generally specific to theGDP-bound state of theG subunits and
excludes association withG. R6A-Gi1 complexes are resistant to tryp-
sin digestion and exhibit distinct stability in the presence of Mg2, sug-
gesting that theR6AandGPRpeptides exert their activities usingdifferent
mechanisms. Studies using Gi1/Gs chimeras identify two regions of
Gi1 (residues 1–35 and 57–88) as determinants for strong R6A-Gi1
interaction. Residues flanking the R6A-1 peptide confer unique binding
properties, indicating that the core motif could be used as a starting point
for the development of peptides exhibiting novel activities and/or speci-
ficity for particular G protein subclasses or nucleotide-bound states.
Heterotrimeric guanine nucleotide-binding proteins (G proteins), com-
posed of , , and  subunits, mediate signaling from transmembrane recep-
tors (GPCRs)3 to a wide variety of effectors (1, 2). In the inactive state, intra-
cellular G-GDP is tightly bound to G to form a G heterotrimer.
Activation of a GPCR results in GDP exchange with GTP in the G subunit,
concomitant dissociation of G, and subsequent signal transduction through
G-GTP and/orG. The inherent guanosine triphosphatase (GTPase) activ-
ity of G, which is accelerated by various GTPase-activating proteins, returns
the protein to the GDP-bound state, resulting in reassociation with G and
termination of signaling.
Approximately 50% of currently marketed drugs target cell surface-accessi-
ble GPCRs (3, 4). Drug discovery targeting intracellular G proteins directly is
inherently difficult due to (i) the broad spectrum of signaling events mediated
at the G protein level, (ii) the requirement that drugs must cross the cell
membrane to reach intracellular G proteins, and (iii) the high sequence and
structural similarities betweenG protein classes (5, 6). Nevertheless, a number
of diseases have been attributed to aberrant G protein activity (7, 8), and direct
G protein ligands will provide new approaches and selectivities for drug treat-
ment (5, 6, 9).
Selection methodologies facilitate the isolation of rare molecules with
unique functions from large libraries (10, 11). Selections with combinatorial
libraries have already been used to identify peptides that bind to various pro-
teins in the G protein signaling cycle (9). We recently demonstrated that
mRNAdisplay, a selection techniquewhere peptides are covalently attached to
their encoded RNA, could be used to isolate Gi1-binding sequences (12). The
dominant peptide from the selection, as well as a minimized, active 9-mer
sequence (R6A-1), act as guanine nucleotide dissociation inhibitors (GDIs)
and compete with G for binding to Gi1 (12).
Here, we examine the specificity of R6A peptides for binding to various in
vitro translated G subunits. Surprisingly, the R6A-1 core motif interacts with
G subunits representing all four G protein families. Binding of R6A-1 is
generally specific for the GDP-bound state of each G subunit and appears to
exclude heterotrimer formation with G. Our findings suggest that the
R6A-1 core motif peptide will be useful for the molecular design of G ligands
with unique specificities.
EXPERIMENTAL PROCEDURES
Materials—Human cDNA clones encoding various G proteins were
obtained from the UMR cDNA Resource Center (www.cdna.org) in the
pcDNA3.1 vector (Invitrogen). The G subunits used were i1, i2, i3, oA, q, s
(short form), 12, and 15. All in vitro translatedG andG subunits refer toG1
and N-terminal hemagglutinin (HA)-tagged G2, respectively. Rat Gi1,
bovine short form Gs and their chimeric constructs were generously pro-
vided by Prof. N. Artemyev (University of Iowa). DNA oligonucleotides were
synthesized by Integrated DNA Technologies, Inc. (Coralville, IA).
Peptide/Protein Preparation—The C-terminal amidated peptides GPR-bi-
otin (TMGEEDFFDL LAKSQSKRLDDQRVDLAGQLRNSYAK, K  biocy-
tin), L19 GPR (TMGEEDFFDLLAKSQSKRLDDQRVDLAGYK), R6A-1-bio-
tin (DQLYWWEYLQLRNSYAK), R6A-1 (DQLYWWEYL), and R6A-4
(SQTKRLDDQLYWWEYL) were synthesized and purified as described pre-
viously (12). R6A-4 lacks an N-terminal methionine that the originally studied
“full-length” R6A peptide contained. Biotinylated peptides were immobilized
using streptavidin-agarose (immobilized NeutrAvidin on agarose, Pierce).
Approximately 500–800 pmol of biotinylated peptide were used per 10 l of
agarose.
Full-length R6A (MSQTKRLDDQLYWWEYL) was expressed as a fusion to
maltose-binding protein (MBP) using an in vivo biotinylation system (13).
Cloning, expression, and purification were performed as described previously
(12). R6A-MBP or MBP was immobilized by random amine coupling on
CNBr-Sepharose 4B (Amersham Biosciences) as per the manufacturer’s
instructions at a concentration of 1 mg/ml hydrated matrix. N-terminal
biotinylated Gi1 (Nb-Gi1) was expressed and purified as described previ-
ously (12). A vector for producing biotinylated Nb-Gs (short form) was con-
structed analogously, except that anN-terminal His6 tag was also incorporated
to facilitate a primary purification by metal chelation chromatography.
In Vitro Translation—All G protein subunits were translated separately in
coupled transcription/translation reactions using the TNT reticulocyte lysate
system (T7 promoter, Promega, Madison, WI). Typically, 0.3–1.0 g of plas-
mid DNA and 25Ci of L-[35S]methionine (MP Biomedicals, Irvine, CA) were
used in a 25-l reaction. Translation efficiency of G subunits was quantitated
by trichloroacetic acid precipitation of a 2-l aliquot of each reaction, as per
the manufacturer’s instructions. G reactions were supplemented with 10 M
mevalonic acid lactone (Sigma) to ensure complete polyisoprenylation (14). To
make G heterodimers, independently translated subunits were mixed
together (3:1 by volume, G:G) and incubated at 37 °C for 30 min. To recon-
stitute G heterotrimers, equal volumes of G and preformed G were
mixed and incubated at 37 °C for an additional 30 min. For the heterotrimer
immunoprecipitation assays, G was translated without radioactive labeling
due to possible interference in the resolution of G subunits by SDS-PAGE.
These unlabeled reactions were supplemented with L-methionine (40 M
final).
G Interaction Assay—G translation reactions were desalted and
exchanged using MicroSpin G-25 columns (Amersham Biosciences) into
buffer (50 mM HEPES-KOH at pH 7.5, 6 mM MgCl2, 75 mM sucrose, 1 mM
EDTA, 1 M GDP, and 0.05% (v/v) Tween 20 (Bio-Rad)). Equivalent aliquots
(2–6 l) of the desalted G subunits were used for the in vitro binding assays.
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Gwas added to 0.6ml of binding buffer (25mMHEPES-KOHat pH 7.5, 5mM
MgCl2, 1mMEDTA, 150mMNaCl, 0.05%Tween 20, 0.05% (w/v) bovine serum
albumin, 1 mM -mercaptoethanol, and 10 M GDP) containing 10-l
matrix with or without immobilized target. After rotating at 4 °C for 1 h,
samples were briefly centrifuged and the supernatant was removed. The
matrix was transferred to a 0.45-m cellulose acetate spin filter (CoStar
Spin-X, Corning, Inc., Corning, NY) and washed with 3  0.6 ml of binding
buffer at 4 °C (1500 g,40 s). Thewashedmatrixwas then removed from the
spin filter for scintillation counting or analysis by SDS-PAGE. An approxima-
tion of the fraction of bound G protein was calculated (bound cpm divided by
input protein counts, as determined by trichloroacetic acid precipitation).
Assays with aluminum fluoride were performed identically, except that the
binding buffer was supplemented with 10 mM NaF and 25 M AlCl3.
G Heterotrimer Immunoprecipitation—Equivalent aliquots (10 l) of
reconstituted G heterotrimer were added to 0.6 ml of binding buffer con-
taining 10-l matrix or 1-l anti-HA monoclonal antibody (Sigma, clone
HA-7). After rotating at 4 °C for 1 h, 10 l of protein G-Sepharose 4B Fast
Flow (Sigma) was added to the monoclonal antibody-containing samples.
After an additional 30 min of rotating at 4 °C, immobilization matrices were
washed in 0.45-m spin filters (3  0.6 ml of binding buffer) as described
above. A fourthwashwas performed in batch, after transferring thematrices to
new tubes, to prevent contamination from the spin filter membrane. The sam-
ples were resuspended in 2 SDS-loading buffer, incubated at 90 °C for 5 min,
and analyzed by Tricine SDS-PAGE. Gels were fixed, dried in vacuo, and
imaged by autoradiography (StormPhosphorImager, AmershamBiosciences).
Trypsin Protection Assay—Gi1 (25 M) in digest buffer (50 mM EPPS at
pH 8.0, 10 mM MgCl2, 2 mM dithiothreitol, 1 mM EDTA, and 10 M GDP or
GTPS) was incubated with and without 1.5-fold excess peptide (R6A-4; R6A-
M1, identical to R6A-1 with the addition of two C-terminal lysines to enhance
solubility; and GPR1, the first GPR motif of AGS3 (15)) and digested with
trypsin (1:50 trypsin:Gi1) at 4 °C for the indicated time. Reactions were ana-
lyzed by SDS-PAGE.
RESULTS ANDDISCUSSION
R6A-1 Is a CoreMotif for GBinding—Previously, in vitro selectionwith an
mRNA display library was used to isolate novel peptide sequences that act as
GDIs for Gi1 (12). The minimal 9-mer peptide, R6A-1, retained high affinity
and competed with G for binding to Gi1. To investigate the binding spec-
ificity of the R6A-1 peptide, a pull-down assay was developed using radiola-
beled, in vitro translated G protein subunits (Fig. 1A). Cell-free coupled tran-
scription/translation offered a rapid method for screeningmultiple G proteins
(16–18). R6A-1 and L19 GPR peptides were synthesized with a C-terminal
biotin-containing linker peptide derived from the constant region used in the
original selection (12). The full-length R6A peptide was also expressed as an
N-terminal fusion to MBP, which was subsequently immobilized by random
amine coupling. [35S]methionine-labeled Gi1 was first tested against immo-
bilized L19 GPR and full-length R6A, demonstrating specific pull-down of
full-length Gi1, as well as a slightly higher mobility band that corresponds to
an alternate translation initiation site (Fig. 1B).
The R6A-1 minimal peptide exhibited strong pull-down for all G subunits
tested (Fig. 2B). There was negligible interaction with H-Ras (a member of the
monomeric or small G protein family), suggesting that the R6A-1 peptide is a
core motif for binding to G subunits in the heterotrimeric G protein family.
Conversely, the L19 GPR peptide was highly specific for Gi1–3 and showed
negligible interaction with other G subunits (Fig. 2A). This contrasts with
previous results that show the GPR consensus exhibits significantly lower, but
detectable, affinity and GDI activity for Go compared with Gi subunits (19,
20). The determined affinities of R6A-1 to Gi1 and Gs (KD200 nM and
50 M, respectively; data not shown) suggest that the sensitivity of the bind-
ing assay was sufficient to detect weak interactions.
FIGURE 1. Binding analysis with in vitro translated G proteins. A, autoradiograph of
indicatedG subunits or H-Ras, directly translated fromhuman cDNAvectors in coupled
transcription/translation reactions with [35S]methionine labeling. A blank reaction ()
did not contain vector. The slightly lower molecular weight bands (seen clearly for Gi1
and Gi3) correspond to translation initiation at alternate methionine codons. B, pull
down of radiolabeled Gi1 onmatrix with () or without () the indicated peptide (L19
GPR or full-length R6A).
FIGURE 3.R6A-MBPandL19GPR competewithG for binding toG subunits.A, in
vitro translated, [35S]methionine-labeledG1 andHA-taggedG2 subunits. B, reconstituted
Gheterotrimers,with the indicatedG subunit, werepulleddownwith an anti-HAanti-
body, R6A-MBP, or L19 GPR. Only the G andG2 subunits were radiolabeled. Immunopre-
cipitation with anti-HA confirmed the presence of reconstituted heterotrimers in the reac-
tion mix. Gwas not co-precipitated when G subunits were pulled down by R6A-MBP or
L19 GPR (B), suggesting that binding of G-GDP to G and R6A are exclusive events (C).
Results were similar for G12 (data not shown).
FIGURE 2.Binding of various in vitro translatedGproteins to L19GPR (A), R6A-1 (B),
or R6A-MBP (C). Binding has been scaled relative to the interaction toGi1. For compar-
ison, KD values of Gi1 binding to L19 GPR, R6A-1, and R6A are 82, 200, and 60 nM,
respectively (12). The negative control matrices used in the assay were streptavidin-
agarose (A and B) and MBP-Sepharose (C). G12 consistently exhibited higher nonspe-
cific binding which was especially noticeable on the MBP-Sepharose in C, which was
background subtracted to more clearly show the binding activity. In B and C, binding
assays were also performed in the presence of aluminum fluoride (AlF) except for G15
(C) and H-Ras (B and C).
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The full-length R6A peptide, compared with the minimal R6A-1 sequence,
demonstrated significantly less binding to Go and Gs and negligible inter-
action with G15 (Fig. 2C). It is not clear whether the differences between R6A
and R6A-1 in relative binding to the various G proteins was due to the N-ter-
minal flanking region of the full-length R6A sequence, the altered immobili-
zation scheme (random amine coupling versusC-terminal biotinylation on the
R6A-1 peptide), or steric effects from the comparatively large MBP fusion.
However, assuming that the various G proteins are structurally homologous
and that the R6A and R6A-1 peptides bind to G subunits analogously, the
differences in relative binding would most likely be a direct result of the R6A
flanking residues.
Previously, it was shown that R6A was highly specific for the GDP state of
Gi1 and did not bind to Gi1-GDP-AlF4 or Gi1-GTPS (12). To establish
the nucleotide state specificity of R6A-derived peptides to various G sub-
units, radiolabeled G proteins were assayed for binding to immobilized R6A-1
and R6A-MBP in the presence and absence of aluminum fluoride. The mini-
mal peptidewas specific for theGDP state of all G proteins except forG12 and
G15, where binding was observed in the presence of aluminum fluoride (Fig.
2B). Full-length R6A-MBP demonstrated strong specificity for the GDP state
of all G proteins, including Gs, confirming the weak but specific interaction
(Fig. 2C). These findings suggest that residues flanking the 9-mer core motif
play a strong role in modulating the binding properties of the peptide, modi-
fying G class as well as nucleotide state specificity.
R6A Competes with G for Binding to G Subunits—Previously, GPR-
and R6A-derived peptides had been shown to compete with G het-
erodimers for binding to Gi1 (12, 21–24). To determine whether R6A would
exclude G binding for other G subunits, in vitro translated G1 and HA-
tagged G2 (Fig. 3A) were reconstituted with various G subunits and pulled
down by immobilized L19 GPR, R6A-MBP, or an anti-HA monoclonal anti-
body. The testedG subunits all appeared to couple toG heterodimers (Fig.
3B). Co-precipitation of G subunits was not seen when heterotrimers were
pulled down by L19GPR or R6A-MBP (Fig. 3B), clearly indicating that binding
to these motifs excludes G interaction (Fig. 3C). Results for R6A-MBP with
reconstituted G1212 heterotrimers were similar (data not shown).
R6A andGPR Peptides Exert DistinctModes of Activity—Previous analyses
of the R6A and GPR peptides suggested that their binding modes and mecha-
nisms of action differ (12). Here, additional assays suggest that R6A binds and
stabilizes a GDP-bound conformation of Gi1 unlike the conformation of the
inactive G-GDP subunit. Mg2 binds with high affinity and stabilizes the
GTP-bound state of G subunits (25). In contrast,Mg2 bindsGi1-GDPwith
weak affinity (25).Measurements of L19GPR andR6Abinding toGi1-GDP as
a function ofMg2 concentration revealed distinct trends (Fig. 4A).While R6A
showed higher relative binding with increasing Mg2 concentrations, L19
GPR exhibited the highest binding in the absence of Mg2. The original isola-
tion of the R6A peptide, from a doped library based on the GPR motif, most
likely resulted from the presence of Mg2 in the selection buffer (12). Crystal
structures of a Gi1-GDP-Mg2 complex indicate that binding of Mg2
induces switch I on Gi1 to assume a conformation similar to that observed in
the active Gi1-GTPS-Mg2 complex (26). Hence, the R6A peptide may
stabilize a conformation of Gi1-GDP that is similar to the structure of an
active, GTP-bound subunit.
Trypsin digestionswere performed to further probe the peptide-boundGi1
complex. GTP-bound G is highly resistant to protease digestion, compared
with theGDP-bound subunit (27, 28). R6Apeptides protectedGi1-GDP from
trypsin similarly to Gi1-GTP (Fig. 4B). Conversely, a GPR peptide-Gi1 com-
plex showed similar proteolysis as Gi1-GDP (Fig. 4B). The R6A and GPR
peptides did not appear to inhibit trypsin directly (data not shown). These
results suggest that the R6A-bound complex is structurally analogous to Gi1-
GTP and further support distinct binding modes and mechanisms of activity
for the R6A and GPR peptides.
Mapping of the R6A-Gi1 Interaction Surface—A series of Gi1/Gs chi-
meric proteins, C1–C8 (Fig. 5A), was used to determine the binding site of the
R6A-1 peptide. The chimeraswere previously shown to be correctly folded and
functional in GTPS binding assays (29). Based on the binding seen for chime-
ras C4, C6, C7, and C8 for immobilized R6A-1, two regions of Gi1 are
required for strong interaction (Fig. 5B). Substitution of residues Gi1-58–88
for the corresponding residues in Gs (comparing chimeras C5 and C6)
resulted in substantially reduced binding. This region, which includes the
linker between the Ras-like and helical domains of Gi1, might be involved in
determining the binding specificity of the R6A peptides. The N-terminal 35
residues of Gi1 also play an important role (comparing chimeras C2 and C5),
most likely by affecting global protein stability and/or conformation.
FIGURE 4. Binding and structural properties of
R6A- and GPR-derived peptides. A, influence of
Mg2onbindingof L19GPRandR6A-MBP toGi1.
Bindingwasmeasured as described for Fig. 2, with
data for each peptide scaled to the maximum
amount of bound G. B, trypsin digest of Gi1-
GDP, Gi1-GTPS, or Gi1-GDP in complex with
the indicated peptide. After binding of nucleotide
and/or peptide, Gi1 complexes were digested
with trypsin at 4 °C for the indicated time and ana-
lyzed by SDS-PAGE. Molecular masses of a protein
ladder (lane 1) are shown in kilodaltons.
FIGURE 5.R6A interactionmapping usingGi1/Gs chimeras. A, schematic represen-
tation of Gi1/Gs chimeras (29). The helical domain (residues 60–175) and switch
regions (residues 176–184, 201–215, and 233–241 for SI, SII, and SIII, respectively) are
marked. Residues 35–57 (gray) are highly conserved among G subunits: between Gi1
and Gs, 20 residues are identical, and the remaining 3 residues are conserved differ-
ences (Lys to Arg or Ile to Leu). Residue numbering is based on the Gi1 sequence. B,
binding of radiolabeled Gi1/Gs chimeras to immobilized L19 GPR or R6A-1. Binding to
the immobilizationmatrix for each protein was0.05, and the results shown have been
background subtracted. The R6A full-length peptide and R6A-1 core motif demon-
strated similar binding results (data not shown).
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Pcp2, a protein containing a single GPR motif, exhibited binding to the G
protein chimeras C4 and C7 (data not shown), agreeing with previous studies
(29). In contrast, the consensus GPR sequence appears to be highly optimized
for specific interaction with Gi as none of the chimeras showed substantial
binding to the L19 GPR peptide (Fig. 5B). Previous studies of different GPR
motif-containing proteins havemapped key binding interactions that promote
class specificity to regions in the G helical domain (29–31). The GPR con-
sensus region itself, however, binds primarily to the G Ras-like domain (30).
Hence, it appears that the determinants for Gi class specificity can be con-
tained within the Ras-like domain, despite the high sequence and structural
conservation of the GPR binding site on G subunits of different classes (9).
TheGPR consensus peptidemay be highly sensitive to the global conformation
of G subunits rather than specific for particular amino acid contacts, perhaps
making the motif easily adaptable for binding to specific G classes (e.g. by the
addition of flanking residues, as in Pcp2 (30)).
We have shown that the R6A-1 peptide, previously identified by in vitro
selection againstGi1, acts as a coremotif for interactionwithG subunits and
appears to compete with G for binding. It will be of interest to determine
whether R6A-1 also retains its GDI activities for different G family members.
The R6A-1 core motif may serve as a template for the molecular design of G
ligands with unique class and/or nucleotide state specificities. Additionally, as
the core motif appears to stabilize a distinct conformation of G-GDP, it may
be possible to develop peptides with unique effects onGprotein-effector inter-
action, GDP exchange, and GTP hydrolysis.
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